journal article·2023-06

A multifunctional composite hydrogel promotes treatment of bisphosphonate-related osteonecrosis of the jaws

Qiuzheng Du, Na Li, Ziwei Jing, Lianping Xue, Haojie Fu, Jiyun Liu, Qingquan Jia, Zhi Sun, Wei He, Xiaojian Zhang

Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Bone health and treatments · Bone and Joint Diseases · Fibroblast Growth Factor Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (33)

Show source-provided references
1. American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw–2014 update10.1016/j.joms.2014.04.031 ↗
2. Surgery-triggered and non surgery-triggered bisphosphonate-related osteonecrosis of the Jaws (BRONJ): a retrospective analysis of 567 cases in an Italian multicenter study10.1016/j.oraloncology.2010.11.007 ↗
3. Osteonecrosis of the jaw–do bisphosphonates pose a risk?10.1056/NEJMp068157 ↗
4. Tetrahedral framework nucleic acid carrying angiogenic peptide prevents bisphosphonate-related osteonecrosis of the jaw by promoting angiogenesis10.1038/s41368-022-00171-7 ↗
5. American association of oral and maxillofacial surgeons position paper: bisphosphonate-related osteonecrosis of the jaws-2009 update: the need to refine the BRONJ definition10.1016/j.joms.2009.07.097 ↗
6. Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings10.1007/s00784-009-0300-6 ↗
7. Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ)
8. The case of medication-related osteonecrosis of the jaw addressed from a pathogenic point of view. innovative therapeutic strategies: focus on the most recent discoveries on oral mesenchymal stem cell-derived exosomes10.3390/ph13120423 ↗
9. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature10.1016/j.ejca.2014.10.015 ↗
10. Antiresorptive drug-related changes of the mandibular bone densitiy in medication-related osteonecrosis of the jaw patients10.1259/dmfr.20190132 ↗
11. Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?10.1016/j.bone.2009.07.011 ↗
12. Transplantation of noncultured stromal vascular fraction cells of adipose tissue ameliorates osteonecrosis of the jaw-like lesions in mice10.1002/jbmr.3292 ↗
13. Myelosuppression alleviation and hematopoietic regeneration by tetrahedral-framework nucleic-acid nanostructures functionalized with osteogenic growth peptide
14. Osteoimmunology: evolving concepts in bone-immune interactions in health and disease10.1038/s41577-019-0178-8 ↗
15. Various therapeutic methods for the treatment of medication-related osteonecrosis of the jaw (MRONJ) and their limitations: a narrative review on new molecular and cellular therapeutic approaches10.3390/antiox10050680 ↗
16. A tetrahedral framework DNA-based bioswitchable miRNA inhibitor delivery system: application to skin anti-aging10.1002/adma.202204287 ↗
17. Bimetal-organic framework-derived nanotube@cellulose aerogels for peroxymonosulfate (PMS) activation10.1016/j.carbpol.2022.119969 ↗
18. Prospects and challenges of dynamic DNA nanostructures in biomedical applications10.1038/s41413-022-00212-1 ↗
19. Signal-off electrochemiluminescence immunosensors based on the quenching effect between curcumin-conjugated Au nanoparticles encapsulated in ZIF-8 and CdS-decorated TiO2 nanobelts for insulin detection10.1039/C9AN02288K ↗
20. Zinc as a therapeutic agent in bone regeneration10.3390/ma13102211 ↗
21. Preparation of antibacterial and osteoconductive 3D-printed PLGA/Cu(I)@ZIF-8 nanocomposite scaffolds for infected bone repair10.1186/s12951-020-00594-6 ↗
22. Accelerated bone regeneration by gold-nanoparticle-loaded mesoporous silica through stimulating immunomodulation10.1021/acsami.9b16848 ↗
23. Advances in engineering hydrogels10.1126/science.aaf3627 ↗
24. Immunostimulatory effect of chitosan and quaternary chitosan: a review of potential vaccine adjuvants10.1016/j.carbpol.2021.118050 ↗
25. Novel chitosan-based pH-sensitive and disintegrable polyelectrolyte nanogels10.1016/j.colsurfb.2014.06.042 ↗
26. Preclinical models of medication-related osteonecrosis of the jaw (MRONJ)
27. Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo10.1007/s10456-013-9381-6 ↗
28. Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw10.1096/fj.201801791RR ↗
29. Signaling—2000 and beyond10.1016/S0092-8674(00)81688-8 ↗
30. Surface chemistry of gold nanoparticles mediates their exocytosis in macrophages10.1021/nn501668a ↗
31. ZIF-8-modified multifunctional bone-adhesive hydrogels promoting angiogenesis and osteogenesis for bone regeneration10.1021/acsami.0c12090 ↗
32. Underlying mechanisms and therapeutic strategies for bisphosphonate-related osteonecrosis of the jaw (BRONJ)10.1248/bpb.b16-01020 ↗
33. Perioperative antibiotic regimen in rats treated with pamidronate plus dexamethasone and subjected to dental extraction: a study of the changes in the jaws10.1016/j.joms.2011.02.059 ↗